###begin article-title 0
Frequent Long-Range Epigenetic Silencing of Protocadherin Gene Clusters on Chromosome 5q31 in Wilms' Tumor
###end article-title 0
###begin p 1
Conceived and designed the experiments: K Malik. Performed the experiments: AR Dallosso, AL Hancock, M Szemes, K Moorwood, L Chilukamarri, HH Tsai, A Sarkar, C Owen, S Malik, M Frank, KW Brown, K Malik. Analyzed the data: AR Dallosso, AL Hancock, KW Brown, K Malik. Contributed reagents/materials/analysis tools: J Barasch, R Vuononvirta, K Pritchard-Jones, B Royer-Pokora, SB Lee, M Frank, A Ward. Wrote the paper: K Malik. Devised array analysis: K Moorwood, KW Brown.
###end p 1
###begin p 2
###xml 462 468 462 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;-</italic>
###xml 470 475 466 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-</italic>
###xml 481 500 474 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;-protocadherin</italic>
###xml 502 506 491 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 562 568 551 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHA@</italic>
###xml 570 576 559 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHB@</italic>
###xml 582 588 571 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHG@</italic>
###xml 783 787 772 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 905 909 894 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 963 967 952 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 1010 1014 999 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 1096 1100 1085 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 1497 1501 1486 1490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pcdh</italic>
###xml 1551 1557 1540 1546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pcdhg@</italic>
###xml 1722 1728 1711 1717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHG@</italic>
###xml 523 528 <span type="species:ncbi:9606">Human</span>
###xml 1411 1417 <span type="species:ncbi:10090">murine</span>
###xml 1445 1448 <span type="species:ncbi:10116">rat</span>
Wilms' tumour (WT) is a pediatric tumor of the kidney that arises via failure of the fetal developmental program. The absence of identifiable mutations in the majority of WTs suggests the frequent involvement of epigenetic aberrations in WT. We therefore conducted a genome-wide analysis of promoter hypermethylation in WTs and identified hypermethylation at chromosome 5q31 spanning 800 kilobases (kb) and more than 50 genes. The methylated genes all belong to alpha-, beta-, and gamma-protocadherin (PCDH) gene clusters (Human Genome Organization nomenclature PCDHA@, PCDHB@, and PCDHG@, respectively). This demonstrates that long-range epigenetic silencing (LRES) occurs in developmental tumors as well as in adult tumors. Bisulfite polymerase chain reaction analysis showed that PCDH hypermethylation is a frequent event found in all Wilms' tumor subtypes. Hypermethylation is concordant with reduced PCDH expression in tumors. WT precursor lesions showed no PCDH hypermethylation, suggesting that de novo PCDH hypermethylation occurs during malignant progression. Discrete boundaries of the PCDH domain are delimited by abrupt changes in histone modifications; unmethylated genes flanking the LRES are associated with permissive marks which are absent from methylated genes within the domain. Silenced genes are marked with non-permissive histone 3 lysine 9 dimethylation. Expression analysis of embryonic murine kidney and differentiating rat metanephric mesenchymal cells demonstrates that Pcdh expression is developmentally regulated and that Pcdhg@ genes are expressed in blastemal cells. Importantly, we show that PCDHs negatively regulate canonical Wnt signalling, as short-interfering RNA-induced reduction of PCDHG@ encoded proteins leads to elevated beta-catenin protein, increased beta-catenin/T-cell factor (TCF) reporter activity, and induction of Wnt target genes. Conversely, over-expression of PCDHs suppresses beta-catenin/TCF-reporter activity and also inhibits colony formation and growth of cancer cells in soft agar. Thus PCDHs are candidate tumor suppressors that modulate regulatory pathways critical in development and disease, such as canonical Wnt signaling.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 45 50 <span type="species:ncbi:9606">human</span>
The development of tissues and organs in the human body requires carefully regulated production of proteins by cells. Proteins permit the growth and development of the many varied structures required for a healthy body. In many diseases, including some cancers, tissues and organs fail to develop as they should due to the normal production of proteins being changed. The work presented here shows that in Wilms' tumor, a childhood cancer of the kidney, a large group of related proteins that are likely necessary for growth and development of a normal kidney are not produced properly. This is due to their production being switched off within the cancer cells. We show how these proteins, known as protocadherins, can themselves alter the function of other proteins already known to be important in normal growth and cancer. Thus our study increases our understanding of how protocadherins are important in normal growth and of how altering protocadherins may lead to disease, such as cancer.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 291 294 291 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Rivera1">[1]</xref>
###xml 623 626 623 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Dallosso1">[2]</xref>
###xml 627 630 627 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Malik1">[3]</xref>
###xml 641 644 641 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Ogawa1">[4]</xref>
###xml 701 704 701 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Brown1">[5]</xref>
###xml 812 817 812 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HACE1</italic>
###xml 844 847 844 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Zhang1">[6]</xref>
###xml 849 855 849 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASSF1</italic>
###xml 862 865 862 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Wagner1">[7]</xref>
###xml 867 872 867 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CASP8</italic>
###xml 880 884 880 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MGMT</italic>
###xml 892 904 892 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASSF5/NORE1</italic>
###xml 916 922 916 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A</italic>
###xml 932 935 932 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Morris1">[8]</xref>
###xml 996 1002 996 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLIPR1</italic>
###xml 1054 1057 1054 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Chilukamarri1">[9]</xref>
Wilms' tumour (WT) represents a paradigm for cancer arising from disrupted development. Failure of the metanephric blastemal cells to undergo mesenchymal to epithelial transition, together with proliferation of these undifferentiated cells, is intrinsic to the development of Wilms' tumours [1]. Thus WT predisposing genes are often critical in normal nephrogenesis. As the aetiology of WTs cannot be explained solely by the known genetic changes, we have evaluated epigenetic changes in WTs. Several epigenetic lesions have previously been identified in Wilms' tumour, in particular loss of imprinting at chromosome 11p13 [2],[3] and 11p15 [4], which we have shown to be early and independent events [5]. In common with other cancers, WTs also show tumour suppressor gene silencing which includes genes such as HACE1 (73% of tumours analysed) [6], RASSF1 (56%) [7], CASP8 (43%), MGMT (30%), RASSF5/NORE1 (15%), and CDKN2A (10-15%) [8]. In addition, we have recently shown over-expression of the GLIPR1 gene resulting from promoter hypomethylation (87%) [9].
###end p 6
###begin p 7
###xml 290 294 278 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 333 358 321 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHA@, PCDHB@ and PCDHG@</italic>
###xml 360 364 348 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Morishita1">[10]</xref>
###xml 524 528 512 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Frigola1">[11]</xref>
###xml 534 538 522 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MLH1</italic>
###xml 553 557 541 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Hitchins1">[12]</xref>
###xml 571 575 559 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXA</italic>
###xml 635 639 623 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Novak1">[13]</xref>
###xml 640 644 628 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Rauch1">[14]</xref>
###xml 972 976 960 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Ying1">[15]</xref>
###xml 977 981 965 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Yu1">[16]</xref>
###xml 1009 1013 997 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Yu2">[17]</xref>
In order to identify candidate genes involved in Wilms' tumorigenesis, we undertook genome-wide analysis of promoter methylation. We have identified pronounced tumour-specific hypermethylation in a region spanning approximately800 kb of chromosome 5q31. This region contains members of the PCDH superfamily in 3 multi-gene clusters (PCDHA@, PCDHB@ and PCDHG@) [10]. Hypermethylation of this locus is an example of long range epigenetic silencing, which has previously been reported in colorectal cancer at chromosome 2q14.2 [11], the MLH1 locus on 3p22 [12], and for the HOXA gene cluster on chromosome 7p15 in breast and lung cancers [13],[14]. We demonstrate that silencing of gene expression is concomitant with DNA hypermethylation and repressive histone modifications. Although little is known about the functions of these clustered PCDHs, other members of the PCDH superfamily have been shown to have tumour suppressor activity, such as PCDH10 in various carcinomas [15],[16] and PCDH8 in breast cancer [17]. Functional data presented here suggest that proteins encoded by the chromosome 5q31 PCDHs modulate the Wnt pathway and are candidate Wilms' tumour suppressor genes.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
A large hypermethylated domain at 5q31 in Wilms' tumour
###end title 9
###begin p 10
###xml 53 63 53 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000745.s001">Figure S1A</xref>
###xml 246 249 246 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H19</italic>
###xml 392 398 392 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASSF1</italic>
###xml 472 475 472 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TBP</italic>
###xml 545 555 545 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000745.s001">Figure S1B</xref>
###xml 591 596 <span type="species:ncbi:9606">human</span>
Following methylated DNA immunoprecipitation (MeDIP, Figure S1A), the efficacy and specificity of the MeDIP protocol was verified using quantitative real-time polymerase chain reaction (PCR) of a constitutively methylated CpG island (CGI) at the H19 imprinting control region, demonstrating successful enrichment relative to input DNA. Specificity for methylated CGIs was shown by PCR of the RASSF1 5' CGI. Amplification of a non-CGI sequence (an intragenic region of the TBP gene), was used as a negative control for methylated DNA enrichment (Figure S1B). Validated MeDIP DNA samples from human fetal kidney and Wilms' tumours were then hybridised to Nimblegen HG18 Refseq promoter microarrays (MeDIP-chip) to detect tumour-specific alterations in methylation.
###end p 10
###begin p 11
###xml 117 118 117 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 125 126 125 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 504 505 504 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 589 597 589 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000745.s009">Table S1</xref>
Microarray data from 5 sporadic WTs were examined to identify promoters displaying tumour-specific hypermethylation (P<0.05, t-test). Overall we found 2043 hypermethylated genes. Significantly, a large subset of these targets were found in 2 or more tumours; pairwise comparisons showed that each individual tumour had between 12.0% and 33.7% (mean 23.8%) of hypermethylated targets in common with the other tumours analysed. The genomic distribution of recurrently hypermethylated genes was non-random (P<0.001, chi square test), with many being located together or within gene clusters (Table S1). Contiguous hypermethylated genes were more likely to be found in several tumours (13 out of 17 loci).
###end p 11
###begin p 12
###xml 81 86 81 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHs</italic>
###xml 241 250 241 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g001">Figure 1A</xref>
###xml 255 265 255 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000745.s001">Figure S1C</xref>
###xml 339 347 339 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000745.s010">Table S2</xref>
###xml 386 411 386 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHA@, PCDHB@ and PCDHG@</italic>
###xml 418 424 418 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHB@</italic>
###xml 480 486 480 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHA@</italic>
###xml 491 497 491 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHG@</italic>
###xml 617 621 617 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Morishita1">[10]</xref>
###xml 699 708 699 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g001">Figure 1A</xref>
###xml 784 788 784 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 812 821 812 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g001">Figure 1B</xref>
###xml 949 953 949 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Alami1">[18]</xref>
###xml 1150 1155 1150 1155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHs</italic>
###xml 1300 1306 1300 1306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASSF1</italic>
###xml 1308 1316 1308 1316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000745.s010">Table S2</xref>
Strikingly, of 146 annotated genes hypermethylated in 3 or more tumours, 25 were PCDHs located at chromosome 5q31 and MeDIP-chip data revealed enriched tumour/normal ratios across 50 closely-linked CGIs spanning 800 kb on chromosome 5q31.3 (Figure 1A and Figure S1C). Hypermethylation at this locus was identified in all tumours examined (Table S2) and hypermethylated CGIs localise to PCDHA@, PCDHB@ and PCDHG@. Each PCDHB@ gene is encoded by a single, unspliced exon, while the PCDHA@ and PCDHG@ genes have unique 5' exons splicing into cluster-specific constant region exons encoding invariant cytoplasmic domains [10]. Proximal and distal boundaries to the hypermethylated domain were apparent (Figure 1A) and, remarkably, tumour MeDIP signal was enriched at virtually all of the PCDH CGIs across the locus (Figure 1B). As a complementary screening approach, we also conducted enrichment of methylated DNA from the WiT49 Wilms' tumour cell-line [18] using recombinant methyl-CpG binding domain (MBD) protein, which permitted microarray methylation profiling without probe DNA amplification. This analysis also showed hypermethylation of multiple PCDHs across the region (data not shown). Both genome-wide analyses identified genes previously known to be hypermethylated in Wilms' tumour, such as RASSF1 (Table S2). Thus our genome-wide promoter analysis identifies a novel region of long-range epigenetic silencing in WTs on chromosome 5q31.3.
###end p 12
###begin title 13
A large hypermethylated domain on chromosome 5q31 in Wilms' tumour.
###end title 13
###begin p 14
###xml 232 238 232 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHA@</italic>
###xml 240 246 240 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHB@</italic>
###xml 251 257 251 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHG@</italic>
###xml 712 716 712 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 755 761 755 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHB@</italic>
###xml 766 772 766 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHG@</italic>
###xml 949 955 949 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHB3</italic>
###xml 957 963 957 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHB8</italic>
###xml 965 972 965 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC25A2</italic>
###xml 974 981 974 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGA3</italic>
###xml 983 990 983 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGA6</italic>
###xml 995 1005 995 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGB4 5&#8242;</italic>
(A) The MeDIP-chip tumour/normal (T/N) signal ratio shown for 2 representative WTs identifies hypermethylation of multiple gene promoters across a domain spanning 800 kb on chromosome 5q31.3 (red box). (B) The MeDIP-chip profile of PCDHA@, PCDHB@ and PCDHG@ in a representative WT. A minority of genes escaping hypermethylation are indicated (black arrowheads). (C) DNA methylation assayed using COBRA. Percentage methylation was analysed by gel densitometry for each gene, and is represented by horizontal bars (black  =  percentage methylated, white  =  percentage unmethylated). Data from 6 normal tissues (4 fetal kidneys [FK], postnatal kidney [NK] and fetal brain [FB]) and 9 Wilms' tumours are shown. Non-PCDH genes flanking the domain and between PCDHB@ and PCDHG@ are also shown. (D) Unsupervised hierarchical clustering of COBRA methylation data from normal and tumour tissues (T), HEK293 and WiT49 cell lines. (E) Bisulfite sequencing of PCDHB3, PCDHB8, SLC25A2, PCDHGA3, PCDHGA6 and PCDHGB4 5' CGIs in normal fetal kidney (FK) and 2 Wilms' tumours, T43 & T57.
###end p 14
###begin title 15
Long-range epigenetic modifications at 5q31 are common in Wilms' tumour but not in preneoplastic lesions
###end title 15
###begin p 16
###xml 268 284 268 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g001">Figure 1C and 1D</xref>
###xml 327 332 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHs</italic>
###xml 459 475 459 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g001">Figure 1C and 1D</xref>
###xml 484 490 484 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHG@</italic>
###xml 581 587 581 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHB@</italic>
###xml 604 610 604 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHA@</italic>
###xml 691 700 691 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g001">Figure 1E</xref>
###xml 733 741 733 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000745.s010">Table S2</xref>
###xml 788 793 788 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHs</italic>
###xml 805 810 805 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHs</italic>
###xml 887 894 887 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGA3</italic>
###xml 936 943 936 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGB4</italic>
###xml 958 965 958 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGA2</italic>
###xml 983 989 983 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHB3</italic>
###xml 1022 1029 1022 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHAC1</italic>
###xml 1031 1055 1031 1055 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHAC2, PCDHB1, PCDHGC3</italic>
###xml 1060 1067 1060 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGC4</italic>
###xml 1141 1157 1141 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g001">Figure 1B and 1C</xref>
###xml 1162 1170 1162 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000745.s010">Table S2</xref>
We used combined bisulfite and restriction analysis (COBRA) to validate and characterise methylation in normal and tumour DNAs. Methylation profiles were consistent with the microarray data, and locus-wide hypermethylation was observed in all tumours and WiT49 cells (Figure 1C and 1D). We also analysed an additional thirteen PCDHs that were identified as hypermethylated by MeDIP-chip, demonstrating that hypermethylation varied between individual tumours (Figure 1C and 1D). Of 19 PCDHG@ genes, 15 were hypermethylated according to COBRA and array analysis, together with 15/16 PCDHB@ genes and 13/15 PCDHA@ genes. Bisulfite sequencing data was consistent with COBRA and MeDIP-chip data (Figure 1E). In total, we analysed 38 WTs (Table S2) and all display hypermethylation of multiple PCDHs, with many PCDHs showing a very high frequency of hypermethylation in tumours. These include PCDHGA3, hypermethylated in 24/27 tumours (89%), PCDHGB4 (23/25, 92%), PCDHGA2 (11/13, 85%) and PCDHB3 (21/33, 64%). COBRA analyses of PCDHAC1, PCDHAC2, PCDHB1, PCDHGC3 and PCDHGC4 showed no evidence of hypermethylation, consistent with MeDIP-chip data (Figure 1B and 1C and Table S2).
###end p 16
###begin p 17
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 122 126 122 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 145 154 145 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000745.s003">Figure S3</xref>
###xml 196 203 196 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGA3</italic>
###xml 208 215 208 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGB4</italic>
###xml 263 272 263 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000745.s004">Figure S4</xref>
###xml 400 407 400 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
Analysis of PCDH methylation in microdissected perilobar nephrogenic rests, presumptive WT precursor lesions, revealed no PCDH hypermethylation (Figure S3) but hypermethylation was evident at the PCDHGA3 and PCDHGB4 genes in a set of stromal-predominant tumours (Figure S4). Taken together our data show that hypermethylation occurs at high frequencies in all WT subtypes, and strongly suggests that de novo methylation arises during neoplastic progression from nephrogenic rest to Wilms' tumour.
###end p 17
###begin p 18
###xml 139 143 139 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 209 214 209 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH1</italic>
###xml 236 242 236 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHG@</italic>
###xml 275 279 275 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 329 336 329 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC25A2</italic>
###xml 406 410 406 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAF7</italic>
###xml 444 453 444 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g001">Figure 1C</xref>
###xml 458 467 458 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000745.s002">Figure S2</xref>
###xml 608 612 608 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
There was no tumour-specific hypermethylation apparent at upstream and downstream CGIs within 100 kb (eight promoter CGIs in total) of the PCDH clusters. A non-clustered protocadherin gene on chromosome 5q31, PCDH1, 300 kb telomeric to PCDHG@, was also unmethylated. Two non-PCDH genes are situated within the methylated domain; SLC25A2 was constitutively methylated in both normal tissues and tumours and TAF7 was constitutively unmethylated (Figure 1C and Figure S2). Thus, their methylation is unaffected by the surrounding epigenetic defect, and tumour-specific hypermethylation is specific to clustered PCDHs.
###end p 18
###begin title 19
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
Silencing of PCDH expression in Wilms' tumour
###end title 19
###begin p 20
###xml 38 44 38 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHA@</italic>
###xml 76 82 76 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHB@</italic>
###xml 87 93 87 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHG@</italic>
###xml 188 194 188 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHG@</italic>
###xml 273 279 273 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHG@</italic>
###xml 435 440 435 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHs</italic>
###xml 526 535 526 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g002">Figure 2A</xref>
###xml 538 545 538 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGC3</italic>
###xml 584 593 584 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g001">Figure 1C</xref>
###xml 600 607 600 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGC3</italic>
###xml 665 674 665 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g002">Figure 2C</xref>
###xml 698 702 698 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 788 797 788 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g002">Figure 2B</xref>
###xml 819 835 819 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGC3, PCDHGA6</italic>
###xml 941 948 941 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGA6</italic>
###xml 953 960 953 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGC3</italic>
###xml 1041 1048 1041 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGA6</italic>
###xml 1094 1101 1094 1101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGA6</italic>
###xml 1120 1129 1120 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g002">Figure 2C</xref>
Quantitative RT-PCR showed negligible PCDHA@ expression in kidney. However, PCDHB@ and PCDHG@ transcripts were readily detectable in fetal kidney, and consistent suppression of methylated PCDHG@ transcripts was apparent in tumours relative to kidney. Of 11 hypermethylated PCDHG@ genes analysed in our tumour panel, 9 showed greater than 90% repression, with the remaining 2 showing very low basal expression in fetal kidney. For many PCDHs, expression in tumours was decreased over 100-fold or below the limits of detection (Figure 2A). PCDHGC3 was consistently unmethylated in WTs (Figure 1C), but PCDHGC3 expression was lowered in WTs relative to normal kidney (Figure 2C). Interestingly, WiT49 PCDH methylation and expression reflects the general silencing pattern observed with WTs (Figure 2B), but in addition to PCDHGC3, PCDHGA6 is also unmethylated in WiT49 cells. Despite the absence of hypermethylation, reduced expression of both PCDHGA6 and PCDHGC3 transcripts relative to fetal kidney was apparent in Wit49 cells. Expression of PCDHGA6 was, however, further suppressed in WTs with PCDHGA6 hypermethylation (Figure 2C).
###end p 20
###begin title 21
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
Silencing of PCDH expression in Wilms' tumour.
###end title 21
###begin p 22
###xml 286 293 286 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC25A2</italic>
###xml 508 512 508 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 584 588 584 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 681 684 681 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TBP</italic>
(A) Expression levels of genes across the locus in 9 tumours (Texp), relative to the mean of 4 normal fetal kidney samples (N exp). Grey bars are used for genes showing tumour-specific hypermethylation, white bars for unmethylated genes and black bars for the constitutively methylated SLC25A2 gene. (B) Expression levels of 5q31 transcripts correspond with DNA methylation status in WiT49 cells. Expression of unmethylated genes (white bars), constitutively methylated genes (black bar) and hypermethylated PCDHs (grey bars) are shown. (C) Suppression of methylated and unmethylated PCDHs within the chromosome 5q31 LRES. Gene expression levels relative to the house-keeping gene TBP are shown. Horizontal black line, median value; box, interquartile range; whiskers, data range excluding outliers; black dots, outliers (defined as those data points greater than range multiplied by inter-quartile range beyond the box). Grey boxes give samples shown to be hypermethylated, open boxes represent unmethylated samples.
###end p 22
###begin p 23
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHB@</italic>
###xml 65 71 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHG@</italic>
###xml 79 85 79 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHB8</italic>
###xml 90 97 90 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHB15</italic>
###xml 152 159 152 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHB12</italic>
###xml 234 243 234 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g002">Figure 2A</xref>
###xml 267 273 267 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHB@</italic>
###xml 342 351 342 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g002">Figure 2B</xref>
###xml 408 413 408 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HARS2</italic>
###xml 418 423 418 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HDAC3</italic>
###xml 446 462 446 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g002">Figure 2A and 2C</xref>
Expression of PCDHB@ genes in tumours was more variable than the PCDHG@ genes. PCDHB8 and PCDHB15 exhibited strong methylation associated silencing but PCDHB12 was not consistently down-regulated in tumours, despite hypermethylation (Figure 2A). All seven methylated PCDHB@ genes analysed were, however, concordantly silenced in WiT49 cells (Figure 2B). Unmethylated genes outside the LRES boundary, such as HARS2 and HDAC3, were not suppressed (Figure 2A and 2C).
###end p 23
###begin p 24
###xml 173 179 173 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHB@</italic>
###xml 184 190 184 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHG@</italic>
###xml 198 207 198 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000745.s005">Figure S5</xref>
###xml 319 327 319 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g002">Figure 2</xref>
To further establish the relationship between methylation and expression, we treated WiT49 cells with 5-azacytidine, which induced the expression of epigenetically silenced PCDHB@ and PCDHG@ genes (Figure S5); in contrast, genes located outside the hypermethylated domain, which showed unaltered expression in tumours (Figure 2), were unaffected by 5-azacytidine. This substantiates the mechanistic link between methylation levels and gene expression at this locus.
###end p 24
###begin p 25
###xml 53 59 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHB@</italic>
###xml 64 70 64 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHG@</italic>
###xml 92 97 <span type="species:ncbi:9606">human</span>
In summary, our expression analyses demonstrate that PCDHB@ and PCDHG@ expression occurs in human kidney, and that epigenetic silencing of gene expression occurs in WT.
###end p 25
###begin title 26
Profiling of histone modifications at active and silenced genes within the 5q31 LRES
###end title 26
###begin p 27
###xml 193 197 193 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 206 214 206 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g003">Figure 3</xref>
###xml 292 296 292 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 363 367 363 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 412 418 412 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHA@</italic>
###xml 420 426 420 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHB@</italic>
###xml 431 437 431 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHG@</italic>
###xml 506 513 506 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC25A2</italic>
###xml 546 550 546 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAF7</italic>
###xml 652 658 652 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHB6</italic>
###xml 660 667 660 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGA6</italic>
###xml 672 679 672 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGC3</italic>
We compared permissive (histone 3 dimethyl lysine 4, H3K4me2; histone 3 acetyl lysine, H3Ac) and repressive (histone 3 dimethyl lysine 9, H3K9me2) histone modifications at gene loci across the PCDH domain (Figure 3) by chromatin immunoprecipitation analysis (ChIP). Genes located outside the PCDH domain were enriched for H3K4me2 and H3Ac. Conversely, methylated PCDHs were enriched for H3K9me2. Hypermethylated PCDHA@, PCDHB@ and PCDHG@ genes all showed repressive histone modifications. As expected, the SLC25A2 (constitutively methylated) and TAF7 (unmethylated) genes were associated with repressive and permissive modifications, respectively. The PCDHB6, PCDHGA6 and PCDHGC3 genes, which were not hypermethylated in the WiT49 cell line, all had an active chromatin profile.
###end p 27
###begin title 28
Hypermethylation across the chromosome 5q31 LRES is associated with specific histone modifications.
###end title 28
###begin p 29
###xml 739 746 739 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC25A2</italic>
Bar charts (left) show ChIP-quantitative PCR measuring relative levels of specific histone modifications at individual gene loci across the 5q31 locus in WiT49 cells. (A) H3Ac ChIP, (B) H3K4me2 ChIP, (C) H3K9me2 ChIP, all expressed relative to input DNA. Scatter plots (right) show the relationship between relative gene expression levels and histone modifications at each gene. The x-axis shows specific histone levels relative to input DNA, and the y-axis shows mRNA expression in WiT49 cells (Texp) relative to average mRNA expression in 4 fetal kidney samples (Nexp). Grey bars/datapoints signify genes hypermethylated in WiT49, open bars/datapoints show unmethylated genes, and the black bar/datapoint shows constitutively methylated SLC25A2.
###end p 29
###begin p 30
###xml 73 95 73 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g003">Figure 3, right panels</xref>
###xml 304 305 304 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 329 330 329 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 495 496 495 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Comparison of gene expression levels, DNA methylation and histone marks (Figure 3, right panels) shows that DNA hypermethylation and silencing correlate with diminished H3Ac and H3K4me2, whereas "active" promoters have high H3Ac and H3K4me2 levels (Spearman rank order correlation coefficient, r = 0.67, P = 0.003, and r = 0.63, P = 0.006 respectively). H3K9me2 shows an opposite pattern, that is high levels at methylated/silenced genes (Spearman rank order correlation coefficient, r = -0.83, P = 0.0002). The degree of H3K9me2 enrichment displays proportionality to gene silencing (Pearson correlation coefficient, r = 0.88). Thus tumour-specific DNA hypermethylation is strongly linked with specific, repressive chromatin modifications, whereas unmethylated genes within, and flanking the region maintain an active chromatin configuration.
###end p 30
###begin title 31
PCDH expression in renal development and differentiation
###end title 31
###begin p 32
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 95 99 95 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Morishita1">[10]</xref>
###xml 136 153 136 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHB@ and PCDHG@</italic>
###xml 183 191 183 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g002">Figure 2</xref>
###xml 206 223 206 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pcdhb@ and Pcdhg@</italic>
###xml 288 294 288 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pcdha@</italic>
###xml 387 404 387 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pcdhb@ and Pcdhg@</italic>
###xml 574 577 574 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wt1</italic>
###xml 628 637 628 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g004">Figure 4A</xref>
###xml 653 657 653 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pcdh</italic>
###xml 707 711 707 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cdh1</italic>
###xml 894 902 894 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g002">Figure 2</xref>
###xml 952 958 952 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHG@</italic>
###xml 1219 1228 1219 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g004">Figure 4B</xref>
###xml 163 168 <span type="species:ncbi:9606">human</span>
###xml 242 248 <span type="species:ncbi:10090">murine</span>
###xml 280 286 <span type="species:ncbi:9606">humans</span>
###xml 786 791 <span type="species:ncbi:9606">human</span>
###xml 928 933 <span type="species:ncbi:9606">human</span>
Previous studies have indicated that PCDH expression is largely restricted to neuronal tissues [10]. As we found abundant expression of PCDHB@ and PCDHG@ genes in human fetal kidney (Figure 2), we examined Pcdhb@ and Pcdhg@ expression during murine kidney development. Similar to humans, Pcdha@ genes were expressed predominantly in brain, with negligible levels in kidney. In contrast, Pcdhb@ and Pcdhg@ expression was abundant in kidney, with expression comparable to brain and exceeding placenta, liver and spleen. Transcript levels followed similar temporal profiles to Wt1, a mediator of mesenchymal-epithelial transition (Figure 4A). Postnatally, Pcdh expression decreases, in contrast to E-cadherin (Cdh1), where high expression levels are maintained in the mature organ. As our human expression analysis was restricted to comparing transcript levels in fetal kidney and Wilms' tumours (Figure 2), we also assessed other human fetal tissues for PCDHG@ encoded proteins by immunoblotting in order to confirm abundant expression in fetal kidney. High expression was also evident in lung and brain, compared with moderate expression in gut. On longer exposure, low expression was also apparent in liver and spleen (Figure 4B).
###end p 32
###begin title 33
Developmental expression patterns of PCDHs.
###end title 33
###begin p 34
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 115 118 115 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tbp</italic>
###xml 312 318 312 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pcdha@</italic>
###xml 323 329 323 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pcdhg@</italic>
###xml 346 350 346 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pcdh</italic>
###xml 378 381 378 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wt1</italic>
###xml 386 390 386 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cdh1</italic>
###xml 811 814 803 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tbp</italic>
###xml 30 35 <span type="species:ncbi:10090">mouse</span>
###xml 147 152 <span type="species:ncbi:10090">mouse</span>
###xml 442 447 <span type="species:ncbi:9606">human</span>
###xml 683 686 <span type="species:ncbi:10116">rat</span>
###xml 847 850 <span type="species:ncbi:10116">rat</span>
###xml 968 974 <span type="species:ncbi:10090">murine</span>
(A) PCDH transcript levels in mouse developmental tissues. Quantitative real-time expression analysis, relative to Tbp, in placenta (P), and E17.5 mouse fetal liver (Li), spleen (S), brain (B), and kidney (K) (E17.5, postnatal 0.5 week, 1 week, and 3 week) using assays specific for the constant region exons of Pcdha@ and Pcdhg@, and individual Pcdh transcripts. Expression of Wt1 and Cdh1 are also shown (black bars). (B) Immunoblotting of human fetal tissue proteins with pan gamma-PCDH antibody or actin for loading control. Samples are kidney (K), liver (Li), lung (Lu), spleen (S), brain (B), and gut (G). (C) Gene expression changes accompanying epithelial differentiation of rat metanephric mesenchyme following Lif, Fgf2, and Tgfalpha treatment. Quantitative real-time expression analysis, relative to Tbp, is shown for freshly dissected rat metanephric mesenchyme (MM) and differentiating mesenchyme (DM). (D) Immunohistochemical analysis of 1-day postnatal murine kidney with antibodies towards Wt1 and gamma-PCDHs. Blastema (b), primitive glomeruli (pg), and ureteric buds (u) are labelled. The control panel shows a section where the primary antibody has been omitted. Bar  = 50 microm.
###end p 34
###begin p 35
###xml 79 85 79 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pcdhb@</italic>
###xml 90 96 90 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pcdhg@</italic>
###xml 295 299 295 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-SchmidtOtt1">[19]</xref>
###xml 375 379 375 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pcdh</italic>
###xml 483 490 483 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pcdhga6</italic>
###xml 492 500 492 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pcdhga12</italic>
###xml 505 508 505 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wt1</italic>
###xml 510 517 510 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pcdhga2</italic>
###xml 522 529 522 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pcdhgc3</italic>
###xml 596 605 596 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g004">Figure 4C</xref>
###xml 637 641 637 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cdh1</italic>
###xml 152 155 <span type="species:ncbi:10116">rat</span>
In order to gain further insight on cell-type specific expression, we analysed Pcdhb@ and Pcdhg@ transcript levels during epithelial differentiation of rat metanephric mesenchymal cells in organ culture. This system has been shown to accurately reflect early differentiation in embryonic kidney [19]. Freshly isolated metanephric mesenchymal cells were found to express high Pcdh levels, and epithelial differentiation induced by growth factors was accompanied by down-regulation of Pcdhga6, Pcdhga12 and Wt1. Pcdhga2 and Pcdhgc3 were also decreased upon differentiation, but to a lesser extent (Figure 4C). As expected, a sharp rise in Cdh1 expression was observed, consistent with increasing epithelialisation.
###end p 35
###begin p 36
###xml 234 240 234 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pcdhg@</italic>
###xml 328 337 324 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g004">Figure 4D</xref>
###xml 637 641 629 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Haas1">[20]</xref>
###xml 642 646 634 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Hambsch1">[21]</xref>
###xml 35 41 <span type="species:ncbi:10090">murine</span>
###xml 68 71 <span type="species:ncbi:10116">rat</span>
###xml 313 319 <span type="species:ncbi:10090">murine</span>
###xml 766 772 <span type="species:ncbi:10090">murine</span>
Comparison of expression levels in murine developmental samples and rat mesenchymal cells suggests that the mesenchyme may be the principal cellular component expressing PCDHs in developing kidney. We therefore assessed expression of Pcdhg@ encoded proteins (gamma-PCDHs) immunohistochemically in postnatal day 1 murine kidney (Figure 4D). High expression was evident in the blastemal cells, with decreasing and more variable expression apparent in tubules and parietal epithelia. Subcellular staining was variable and included nuclear staining, which is consistent with a role for the gamma-PCDH intracellular domain in gene regulation [20],[21]. Expression in the ureteric bud and visceral epithelia was low or absent. Thus gamma-PCDHs proteins are evident in the murine equivalent of the presumptive multipotent cell of origin for WT. This is consistent with PCDHs having a role in kidney development and Wilms' tumorigenesis.
###end p 36
###begin title 37
Modulation of canonical Wnt signalling by PCDHs
###end title 37
###begin p 38
###xml 166 170 163 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Yang1">[22]</xref>
###xml 335 339 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-SchmidtOtt2">[23]</xref>
###xml 469 473 460 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Giles1">[24]</xref>
###xml 710 714 694 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Veeman1">[25]</xref>
###xml 806 812 790 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHG@</italic>
###xml 911 915 895 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 932 936 916 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 952 959 936 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGA6</italic>
###xml 964 971 948 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGC3</italic>
###xml 1065 1074 1049 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g002">Figure 2C</xref>
Little is known about PCDH cellular functions, but a member of the PCDH superfamily, PCDH-PC, was previously shown to positively regulate beta-catenin/TCF signalling [22]. The Wnt signalling pathway, which utilises the beta-catenin/TCF transcriptional complex to programme developmental gene expression, is essential for nephrogenesis [23]. Constitutive Wnt signalling brought about by compromised beta-catenin function is also involved in several cancers including WT [24]. We therefore assessed the possible effects of gamma-PCDH knockdown on beta-catenin/TCF mediated transcription using luciferase reporter plasmids which contain a minimal promoter adjacent to 7 tandem TCF binding sites (Super8xTOPFLASH, [25]). Short-interfering RNAs (siRNAs) were designed to target the constant region sequences of PCDHG@ and transfected into WiT49 cells. Although WiT49 cells show extensive hypermethylation across the PCDH locus, specific PCDHs (for example, PCDHGA6 and PCDHGC3) escape hypermethylation and are expressed, albeit at lower levels relative to fetal kidney (Figure 2C); WiT49 cells also exhibit intermediate Wnt signalling activity in the absence of beta-catenin mutations, and are therefore suitable for investigating PCDH effects on the Wnt pathway.
###end p 38
###begin p 39
###xml 222 228 211 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHG@</italic>
###xml 371 377 360 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTNNB1</italic>
###xml 481 490 467 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g005">Figure 5A</xref>
###xml 643 652 622 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g005">Figure 5A</xref>
###xml 671 677 650 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTNNB1</italic>
###xml 817 822 789 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCND1</italic>
###xml 824 828 796 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMYC</italic>
###xml 833 837 805 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PAX8</italic>
###xml 878 881 850 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT1</italic>
###xml 883 892 855 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g005">Figure 5B</xref>
###xml 1132 1141 1101 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g005">Figure 5C</xref>
###xml 1242 1246 1208 1212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Brattain1">[26]</xref>
###xml 1247 1251 1213 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Ilyas1">[27]</xref>
###xml 1270 1274 1236 1240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 1293 1302 1259 1268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000745.s006">Figure S6</xref>
###xml 1620 1626 1583 1589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHG@</italic>
###xml 977 982 <span type="species:ncbi:9606">human</span>
The activity of the beta-catenin/TCF reporter was increased by knockdown of gamma-PCDHs, suggesting that gamma-PCDHs negatively influence the canonical Wnt pathway. A second siRNA targeting a different sequence within the PCDHG@ constant region gave similar results, negating the possibility of off-target effects (data not shown). Reporter upregulation was abolished by CTNNB1 siRNA co-transfection, demonstrating that enhanced TCF-mediated activation was beta-catenin-dependent (Figure 5A). This was further supported by immunoblot analysis which showed that knockdown of gamma-PCDHs was accompanied by elevated beta-catenin protein levels (Figure 5A, inset), although CTNNB1 transcript levels were unchanged (data not shown). Knockdown of gamma-PCDHs also induced expression of known beta-catenin/TCF target genes CCND1, CMYC and PAX8, as well as repressing transcription of WT1 (Figure 5B). We also individually over-expressed PCDHGA2, PCDHGA6 and PCDHGA12 in WiT49 cells, human embryonic kidney 293 cells (HEK293) treated with Wnt3a conditioned media and HCT116 cells to evaluate effects on beta-catenin/TCF reporter activity (Figure 5C). The latter cell-line is derived from a colorectal cancer with an activating beta-catenin mutation [26],[27] and also displays PCDH hypermethylation (Figure S6). PCDH-mediated suppression of beta-catenin/TCF reporter activity was evident in all cell-lines, especially Wnt3a-treated HEK293 and HCT116, both of which have high Wnt signalling. As expected, expression of a dominant-negative form of TCF4 also strongly reduced reporter activity. Taken together, our data implicate PCDHG@ encoded proteins in negative modulation of canonical Wnt signalling.
###end p 39
###begin title 40
PCDH effects on Wnt signalling.
###end title 40
###begin p 41
###xml 81 87 74 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHG@</italic>
###xml 493 496 476 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TBP</italic>
###xml 548 553 531 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCND1</italic>
###xml 555 559 538 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CMYC</italic>
###xml 565 569 548 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PAX8</italic>
###xml 627 630 606 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT1</italic>
(A) Enhanced beta-catenin/TCF activity following gamma-PCDH knockdown induced by PCDHG@ constant region targeting siRNA, measured with Super8xTOPFLASH reporter (TOP). Super8xFOPFLASH (FOP) reporter is a negative control. RLU, relative luciferase units. Gamma-PCDH and beta-catenin knockdowns are verified by immunoblotting (IB) in the inset, which also demonstrates increased cellular beta-catenin accompanying gamma-PCDH knockdown. (B) Quantitative real-time expression analysis, relative to TBP, showing induction of the Wnt pathway target genes CCND1, CMYC, and PAX8 accompanying gamma-PCDH knockdown; altered expression of WT1 is also shown. (C) Repression of beta-catenin/TCF reporter activity accompanying PCDH expression in WiT49, HCT116, and Wnt3a-conditioned medium treated HEK293 (HEK293+CM) cells. A plasmid containing a cDNA encoding dominant-negative TCF4 (TCF4-DN) is also shown as a positive control. Cells were co-transfected with PCDH expression vectors and Super8xTOPFLASH (TOP) or Super8xFOPFLASH (FOP) and luciferase activity measured. RLU, relative luciferase units.
###end p 41
###begin p 42
###xml 327 331 327 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Ying1">[15]</xref>
###xml 366 373 366 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGA2</italic>
###xml 375 382 375 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGA6</italic>
###xml 386 394 386 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGA12</italic>
###xml 505 506 505 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 515 516 515 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 524 525 524 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 635 636 635 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 704 705 704 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 714 723 714 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g006">Figure 6A</xref>
###xml 855 861 855 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTNNB1</italic>
###xml 960 969 957 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000745.s007">Figure S7</xref>
As our epigenetic and functional analyses allude to a tumour suppressor function for PCDHs, we evaluated the effect of ectopic PCDH expression on tumour-related phenotype using cell-culture based assays commonly used for assessing tumour suppressor gene function, that is inhibition of colony formation and growth in soft agar [15]. Transfection of WiT49 cells with PCDHGA2, PCDHGA6 or PCDHGA12 resulted in moderate PCDH protein expression leading to approximately 30-85% suppression of colony formation (P<0.05 to P<0.005, t-test). Similarly transfection of HCT116 cells resulted in approximately 70% suppression of colony formation (P<0.01), and transfection of HEK293 cells led to 60-85% suppression (P<0.005) (Figure 6A). Suppression of colony formation was not a non-specific side-effect of gene over-expression, as transfection of HEK293 cells with CTNNB1 cDNA encoding a degradation-resistant mutant of beta-catenin failed to suppress colony formation (Figure S7).
###end p 42
###begin title 43
Growth inhibition by PCDHs.
###end title 43
###begin p 44
###xml 99 103 99 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
(A) Suppression of WiT49, HCT116, and HEK293 cell colony formation following ectopic expression of PCDH cDNAs. After selection and staining, plates were photographed and colony counts determined for each transfection. Representative plates (left) and mean colony counts (right) are shown, Verification of PCDH protein expression after transfection, together with tubulin as a loading control is shown below the histograms. (B) Inhibition of anchorage-independent growth of HCT116 cells by PCDHs, cells were plated in triplicate and colonies formed after 10-14 days were photographed and counted within 10 random fields. Representative fields are shown (left) together with colony forming efficiency (CFE), expressed as percentage of colonies >50 microm diameter (right). Cell-based assays were repeated at least twice, and representative data are shown.
###end p 44
###begin p 45
###xml 112 121 112 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000745-g006">Figure 6B</xref>
We also assessed the effect of PCDH expression on anchorage independent growth in soft agar using HCT116 cells (Figure 6B). Colony forming efficiency was markedly reduced by PCDHGA2, PCDHGA6 and PCDHGA12 relative to cells transfected with expression vector only (approximately 85%-95% suppression relative to the vector control).
###end p 45
###begin p 46
Collectively, therefore, our experiments demonstrate that PCDHs regulate critical transduction and transcription pathways and have growth regulatory properties consistent with tumour suppressor activity.
###end p 46
###begin title 47
Discussion
###end title 47
###begin p 48
###xml 106 110 106 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 215 219 215 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 247 251 247 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
By conducting genome-wide promoter methylation analysis, we have identified a large cluster of paralogous PCDH genes on chromosome 5q31 which undergo hypermethylation in Wilms' tumours. Transcriptional silencing of PCDHs was prevalent in WTs, and PCDH hypermethylation constitutes the most frequent epigenetic silencing event in WT. This putative WT suppressor domain is the first report of LRES in childhood tumours. Our data also suggests roles for PCDHs in normal nephrogenesis, including modulation of key regulatory pathways such as canonical Wnt signalling.
###end p 48
###begin p 49
###xml 77 81 77 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Novak1">[13]</xref>
###xml 89 93 89 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Frigola1">[11]</xref>
###xml 94 98 94 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Hitchins1">[12]</xref>
###xml 120 124 120 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Rauch1">[14]</xref>
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Smith1">[28]</xref>
###xml 130 134 130 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Liu1">[29]</xref>
###xml 350 354 350 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 476 481 476 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HOXD@</italic>
###xml 502 507 502 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIST1</italic>
###xml 524 528 524 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Novak2">[30]</xref>
###xml 581 589 581 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000745.s009">Table S1</xref>
###xml 849 856 849 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGC3</italic>
LRES regions have been identified in several adult cancers including, breast [13], colon [11],[12], head, neck and lung [14],[28],[29]. A recent genome-wide analysis of methylation in breast cancers showed that multiple agglomerative epigenetic aberrations occur, including regions undergoing hypermethylation and hypomethylation. Interestingly, the PCDH locus on chromosome 5q31 was one of several hypermethylated domains shown in breast cancer, together with others such as HOXD@ on chromosome 2 and HIST1 on chromosome 6 [30]. Such regions were also identified in our analysis (Table S1). Thus, in addition to gene-specific epigenetic lesions, our study shows that some, but not all, LRES domains are conserved between embryonal and adult cancers. Also individual genes within an LRES region can show tumour-type specific changes, illustrated by PCDHGC3 which is frequently hypermethylated in breast cancer but which escapes methylation in WTs. The contribution of LRES to tumour pathology is not well characterised, but transcriptional suppression of multiple genes across a chromosomal region can be considered to be functionally analogous to cytogenetic loss.
###end p 49
###begin p 50
###xml 302 306 302 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Frigola1">[11]</xref>
###xml 307 311 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Hitchins1">[12]</xref>
###xml 344 348 344 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 364 368 364 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAF7</italic>
###xml 373 380 373 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC25A2</italic>
###xml 623 630 623 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGC3</italic>
###xml 635 642 635 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGA6</italic>
###xml 774 781 774 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGA6</italic>
###xml 786 793 786 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGC3</italic>
###xml 1142 1146 1130 1134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 1148 1152 1136 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Haas1">[20]</xref>
###xml 1153 1157 1141 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Hambsch1">[21]</xref>
Silencing of individual genes within the LRES domains on chromosome 2q and 3p in colorectal cancer appears to be dependent on a domain-wide non-permissive chromatin configuration, rather than the methylation status, as unmethylated genes within these domains and up to 1000 kb away are also suppressed [11],[12]. By contrast, expression of non-PCDH genes at 5q31 (TAF7 and SLC25A2) was strongly linked to methylation status in WTs, and the transcriptional status of unmethylated genes flanking the LRES was unchanged in tumours. A comparatively lesser degree of transcriptional suppression is observed for the unmethylated PCDHGC3 and PCDHGA6 genes in WiT49 cells. This suppression occurs despite any significant changes in active/repressive histone marks and suggests that PCDHGA6 and PCDHGC3 are repressed by a non-epigenetic effect such as altered feedback regulation resulting from lowered levels of gamma-PCDH intracellular domain fragments. Similar to the Notch signalling paradigm, regulated presenilin dependent-processing of the gamma-PCDHs generates C-terminal fragments which can localize to the nucleus and autoregulate the gamma-PCDHs [20],[21].
###end p 50
###begin p 51
###xml 29 33 29 33 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Novak2">[30]</xref>
###xml 117 121 117 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 184 188 184 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Frigola1">[11]</xref>
###xml 189 193 189 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Hitchins1">[12]</xref>
###xml 496 502 496 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A</italic>
###xml 502 506 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Bachman1">[31]</xref>
###xml 803 806 803 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 824 829 824 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 870 874 870 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Keshet1">[32]</xref>
###xml 1044 1051 1044 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 1099 1103 1099 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Schlesinger1">[33]</xref>
###xml 1244 1249 1244 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHs</italic>
###xml 1289 1293 1289 1293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Lee1">[34]</xref>
###xml 1424 1428 1424 1428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Keshet1">[32]</xref>
###xml 1473 1478 1473 1478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHs</italic>
###xml 1569 1573 1569 1573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 1610 1617 1610 1617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 1812 1819 1812 1819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGC3</italic>
###xml 1163 1168 <span type="species:ncbi:9606">human</span>
In contrast to breast cancer [30], our ChIP data shows a strong link between DNA methylation and H3K9me2 at silenced PCDH genes, as reported for the LRES on chromosome 2q14.2 and 3p22 [11],[12]. Indeed a correlation between degree of silencing and H3K9me2 enrichment was apparent, whereas H3K4me2 and H3Ac marking is evident in all active genes and lost in silenced genes. This suggests that H3K9me2 plays a role in establishing and maintaining the silenced state, as previously demonstrated for CDKN2A[31], and that histone 3 acetylation and H3K4me2 marks are removed prior to increases in H3K9me2 and DNA methylation. It has been postulated that a significant proportion of hypermethylated loci in cancer do not arise by adaptive selection but rather are the result of an 'instructive' mechanism, via cis-targeting of the trans-acting Polycomb group protein-complexes [32], and that these loci are pre-marked in normal (unmethylated) tissues by histone H3 trimethyl - lysine27 (H3K27me3). The instructive mechanism may explain the non-random de novo methylation of some genes during tumorigenesis [33]. However, in the case of the 5q31 LRES, a genomic study of human embryonic stem cells failed to identify pre-marking of the hypermethylated PCDHs by Polycomb group proteins or H3K27me3 [34]. Additionally, the instructive mechanism predicts methylation would be present in pre-cancerous lesions (e.g. colorectal adenomas [32]) and we have shown this is not the case for PCDHs, which are unmethylated in nephrogenic rests, pre-cancerous lesions for WT. Therefore the PCDHs do not appear to be pre-marked for de novo methylation in WT, indicating that this molecular lesion is selected for during tumorigenesis. This is also supported by tumour-type specific variations in hypermethylation such as observed for PCDHGC3, as discussed above.
###end p 51
###begin p 52
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 108 114 108 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASSF1</italic>
###xml 116 123 116 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DNAJC15</italic>
###xml 124 127 124 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MCJ</italic>
###xml 132 140 132 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFRSF25</italic>
###xml 163 167 163 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Ehrlich1">[35]</xref>
###xml 229 235 229 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLIPR1</italic>
###xml 355 358 355 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Chilukamarri1">[9]</xref>
###xml 383 389 383 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLIPR1</italic>
###xml 476 482 476 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLIPR1</italic>
###xml 516 521 516 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHs</italic>
###xml 759 763 759 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
Hypermethylation of PCDHs was not detectable in nephrogenic rests, consistent with a previous assessment of RASSF1, DNAJC15/MCJ and TNFRSF25 gene hypermethylation [35]. This is in contrast to gene-specific hypomethylation of the GLIPR1 gene observed in WTs, where nephrogenic rests display intermediate methylation levels relative to fetal kidney and WTs [9]. Therefore although the GLIPR1 hypomethylation observed in WTs might reflect an expansion of oncofetal cells lacking GLIPR1 methylation, hypermethylation of PCDHs and other tumour suppressor genes appears to represent a later, tumour-specific lesion. Expression of PCDHs in blastemal cells, together with our methylation analysis of nephrogenic rests, also negates the possibility that Wilms' tumour PCDH hypermethylation can be attributed to clonal expansion of progenitors with cell-type specific methylation.
###end p 52
###begin p 53
###xml 92 96 92 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Charles1">[36]</xref>
###xml 101 107 101 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTNNB1</italic>
###xml 118 122 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Fukuzawa1">[37]</xref>
###xml 192 196 192 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Filippova1">[38]</xref>
###xml 273 277 273 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 284 288 284 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Kim1">[39]</xref>
Genetic lesions in WT known to be late events include chromosome 16q loss of heterozygosity [36] and CTNNB1 mutations [37]; interestingly, the CTCF gene locates to 16q, is mutated in some WTs [38] and the encoded epiregulatory protein has multiple binding sites across the PCDH locus [39], suggesting that aberrant CTCF function may be involved in LRES.
###end p 53
###begin p 54
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pcdhs</italic>
###xml 114 118 114 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cdh1</italic>
###xml 315 321 315 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pcdhg@</italic>
###xml 441 448 441 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pcdhb15</italic>
###xml 453 461 453 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pcdhga12</italic>
###xml 530 534 530 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Brunskill1">[40]</xref>
###xml 598 602 598 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pcdh</italic>
###xml 739 743 739 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Kobayashi1">[41]</xref>
###xml 749 753 749 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 949 955 949 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pcdhg@</italic>
###xml 1125 1129 1125 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Wang1">[42]</xref>
###xml 1225 1231 1225 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pcdhg@</italic>
###xml 1434 1440 1434 1440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pcdhg@</italic>
###xml 1502 1508 1502 1508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pcdhg@</italic>
###xml 1526 1533 1526 1533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000745.s013">Text S1</xref>
###xml 1593 1596 1593 1596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wt1</italic>
###xml 1650 1654 1650 1654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Menke1">[43]</xref>
###xml 1773 1782 1773 1782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000745.s008">Figure S8</xref>
###xml 1918 1924 1918 1924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pcdhg@</italic>
###xml 220 223 <span type="species:ncbi:10116">rat</span>
###xml 622 628 <span type="species:ncbi:10090">murine</span>
###xml 777 782 <span type="species:ncbi:9606">human</span>
###xml 804 810 <span type="species:ncbi:10090">murine</span>
###xml 832 835 <span type="species:ncbi:10116">rat</span>
###xml 963 967 <span type="species:ncbi:10090">mice</span>
###xml 1239 1243 <span type="species:ncbi:10090">mice</span>
###xml 1312 1318 <span type="species:ncbi:10090">murine</span>
###xml 1446 1450 <span type="species:ncbi:10090">mice</span>
###xml 1516 1520 <span type="species:ncbi:10090">mice</span>
Expression of the Pcdhs peaks in the last week of nephrogenesis; thereafter, expression decreases, in contrast to Cdh1, which encodes the archetypal epithelial adhesion protein, E-cadherin. Epithelial differentiation of rat metanephric mesenchyme cells in organ culture was also accompanied by decreasing levels of Pcdhg@ expression. A recent microarray analysis of gene expression with laser captured kidney components showed expression of Pcdhb15 and Pcdhga12 expression attenuating between the cap mesenchyme and renal vesicle [40]. Together with our expression analyses, this suggests that the Pcdh expression peak in murine nephrogenesis likely reflects the expansion of nephrogenic progenitors as kidney development nears completion [41]. Our PCDH expression analyses in human fetal kidney, during murine nephrogenesis and in rat metanehpric mesenchyme suggest that PCDHs may have hitherto uncharacterised roles in renal development. Although Pcdhg@ mutant mice, which undergo neurodegeneration and neonatal death in less than 12 hours, did not show a gross kidney phenotype, kidney defects were not explored in detail [42] (Wang & Sanes, personal communication). The early postnatal lethality observed with homozygous Pcdhg@ mutant mice would also preclude full assessment of effects on nephrogenesis, as murine kidney development continues in the first week following birth. Although we were unable to assess renal defects in Pcdhg@ null mice, we did examine postnatal kidney from heterozygous Pcdhg@ mutant mice (see Text S1), as heterozygous mutations of developmental genes such as Wt1 have been shown to result in end-stage renal disease [43]. Histological examination of kidneys from 3 month old heterozygotes showed no evidence of overt kidney malformations (Figure S8). However, it will clearly be of great interest to analyse a larger heterozygous cohort together with embryonic kidney from homozygous Pcdhg@ mutants in future studies.
###end p 54
###begin p 55
###xml 256 260 253 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Park1">[44]</xref>
###xml 619 624 603 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHs</italic>
###xml 744 747 725 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT1</italic>
###xml 1072 1076 1053 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 1267 1273 1242 1248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTNNB1</italic>
###xml 1278 1281 1253 1256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WTX</italic>
###xml 1299 1303 1274 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Ruteshouser1">[45]</xref>
###xml 1304 1308 1279 1283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Koesters1">[46]</xref>
###xml 1318 1324 1293 1299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTNNB1</italic>
###xml 1343 1347 1318 1322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 1770 1774 1742 1746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 2061 2065 2033 2037 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 2096 2100 2068 2072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Novak2">[30]</xref>
###xml 2210 2214 2179 2183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Howe1">[47]</xref>
The canonical Wnt signalling pathway is a prerequisite for initiating and maintaining mesenchymal to epithelial transitions during kidney development, and it is also known that mesenchyme with high beta-catenin activity fails to form epithelial structures [44]. Thus attenuation of Wnt signalling is necessary during nephrogenesis. Importantly, our functional analysis shows that gamma-PCDHs repress beta-catenin/TCF mediated transcription, with lowered PCDH leading to elevated beta-catenin protein, high beta-catenin/TCF reporter activity and induced expression of Wnt target genes. Conversely, ectopic expression of PCDHs was able to suppress beta-catenin/TCF reporter activity in heterologous cell systems. In contrast to Wnt target genes, WT1 expression levels were reduced by PCDH knockdown, demonstrating that Wnt target gene induction is not reflecting a generalised increase in transcription and that other regulatory networks are also influenced by cellular PCDH levels. The significance of these results is underlined by our findings of epigenetic silencing of PCDHs in WT, as this would be predicted to lead to elevated beta-catenin/TCF activity. In this regard, it is notable that enhanced beta-catenin signalling in WTs is observed more frequently than CTNNB1 and WTX mutations in WTs [45],[46] and that CTNNB1 mutation is, like PCDH silencing, a late event in Wilms' tumorigenesis. Although our analysis of PCDHs on Wnt signalling can only approximate the permutational silencing in WTs, our results prompt the hypothesis that the canonical Wnt pathway is modulated by PCDHs, and that in normal nephrogenesis, elevated PCDHs serve to downregulate beta-catenin activity, thereby permitting completion of epithelial differentiation. Epigenetic silencing of PCDHs might contribute to deregulation of Wnt signalling, and a failure of mesenchymal to epithelial transition resulting in persistence of a progenitor cell pool and consequent Wilms' tumorigenesis. PCDHs may also have a role in the aetiology of other cancers, such as breast cancer, where PCDH hypermethylation is prevalent [30] and activation of Wnt/beta-catenin signalling occurs, despite mutations of Wnt pathway components being rare [47].
###end p 55
###begin p 56
###xml 200 204 200 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Haas1">[20]</xref>
###xml 205 209 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Hambsch1">[21]</xref>
###xml 323 327 315 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Chen1">[48]</xref>
###xml 385 389 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-vanBuul1">[49]</xref>
###xml 489 493 475 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Daugherty1">[50]</xref>
###xml 566 570 552 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 700 704 683 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
Although the mechanisms by which PCDHs influence pathways such as Wnt signalling require delineation, we note that, as well as encoding a nuclear moiety capable of regulating gene expression directly [20],[21], alpha- and gamma-PCDHs have recently been reported to negatively regulate proline-rich tyrosine kinase 2 (PYK2) [48] which was previously shown to phosphorylate beta-catenin [49]. As phospho-regulation of beta-catenin can promote interactions with transcriptional co-activators [50], we speculate that elevated PYK2 activity may arise as a consequence of PCDH silencing and thereby lead to a shift of the beta-catenin adhesion/signalling balance. This and other downstream consequences of PCDH silencing warrant intensive future study.
###end p 56
###begin title 57
Materials and Methods
###end title 57
###begin title 58
Ethical statement
###end title 58
###begin p 59
###xml 4 9 <span type="species:ncbi:9606">human</span>
All human tissues were acquired with appropriate local research ethics committee approval and all animal procedures were conducted in accordance with regulations (UK Home Office) and international standards on animal welfare.
###end p 59
###begin title 60
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient samples
###end title 60
###begin p 61
###xml 275 283 275 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000745.s011">Table S3</xref>
###xml 66 74 <span type="species:ncbi:9606">Children</span>
###xml 147 155 <span type="species:ncbi:9606">Children</span>
###xml 168 173 <span type="species:ncbi:9606">Human</span>
All tissues were obtained as snap frozen samples from the Bristol Children's Hospital, the Royal Marsden Hospital and the University of Heidelberg Children's Hospital. Human fetal tissue samples were from 19 to 31 weeks of gestation. Details of clinical samples are given in Table S3.
###end p 61
###begin title 62
Cell culture, transfections, and reporter assays
###end title 62
###begin p 63
###xml 6 10 6 10 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Alami1">[18]</xref>
###xml 19 22 19 22 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Chilukamarri1">[9]</xref>
###xml 98 102 98 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Graham1">[51]</xref>
###xml 308 309 302 303 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 69 74 <span type="species:ncbi:9606">human</span>
###xml 214 218 <span type="species:ncbi:9913">calf</span>
###xml 409 413 <span type="species:ncbi:9913">calf</span>
WiT49 [18], HCT116 [9] and HEK293 cell-lines (adenovirus transformed human embryonic kidney cells [51]) were cultured using standard methods in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum, 2 mmol/l L-glutamine, 0.1 mg/ml penicillin/streptomycin, at 37degreesC under 5% CO2. L/Wnt3a fibroblast cell lines (ATCC, Manassas, VA) were grown in DMEM supplemented with 10% fetal calf serum, and Wnt3a conditioned medium was prepared according to the protocol provided by ATCC ().
###end p 63
###begin p 64
###xml 208 209 205 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 514 518 511 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Veeman1">[25]</xref>
###xml 370 374 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
For knockdown analyses, cells were transfected with DharmaFECT DUO (Dharmacon, Inc.) with 50 nM total of ON-TARGETplus short interfering RNA (siRNA) duplexes. For beta-catenin/TCF reporter activity assays, 105 cells/well were seeded in 24-well plates and 100 ng of Super 8xTOPFLASH or Super 8xFOPFLASH reporter plasmids were co-transfected with siRNAs and 100 pg of pRL-SV40 to normalise for transfection efficiency. Super 8xFOPFLASH is a negative control for Super 8xTOPFLASH containing mutated TCF binding sites [25]. Luciferase samples were assayed after 48 hours using Dual-luciferase reporter kit (Promega) and a Modulus Luminometer (Turner Biosystems). Experiments were performed at least twice in triplicate.
###end p 64
###begin p 65
###xml 632 636 616 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-SchmidtOtt1">[19]</xref>
###xml 4 7 <span type="species:ncbi:10116">rat</span>
###xml 85 88 <span type="species:ncbi:10116">rat</span>
For rat mesenchymal organ culture, dissected fresh metanephric mesenchyme from E13.5 rat embryos was cultured on collagen coated transwell filters (Corning) in DMEM/F12 media containing 20 mg/ml penicillin/streptomycin, 10 microg/ml insulin, 10 microg/ml transferrin, 10 ng/ml selenium (ITS), 40 ng/ml dexamethasone, 100 ng/ml prostaglandin, 4 ng/ml tri-iodo-l-thyronine, 10 ng/ml holo-transferrin. Epithelial differentiation was induced over 5 days with 50 ng/ml leukemia inhibitory factor (Lif, Chemicon), 20 ng/ml transforming growth factor alpha (Tgfalpha, R&D Systems) and 50 ng/ml fibroblast growth factor (Fgf2, R&D Systems) [19], after which RNA was extracted with Tri reagent (Sigma).
###end p 65
###begin p 66
###xml 169 170 166 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 429 430 426 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
For PCDH over-expression studies, cDNAs were obtained by RT-PCR from fetal kidney RNA and cloned into pCDNA3.1/Zeo (Invitrogen). For beta-catenin/TCF reporter assays, 105 cells/well were seeded in 24-well plates and transfected with 400 ng of expression constructs together with 100 ng Super 8xTOPFLASH or Super 8xFOPFLASH using Fugene 6 (Roche), and assayed for luciferase as described above. For colony formation assays, 2.5x105 HCT116 and WiT49 cells were transfected with 1 ug of expression plasmids in 6-well plates and plated in triplicate in 10 cm dishes 48 hours after transfection. Selection was performed with 200 microg/ml (HCT116) or 100 microg/ml (WiT49) of zeocin (Invitrogen) for 2 weeks after which colonies were methylene blue stained and counted using ImageJ software (). Colony formation assays were repeated at least twice.
###end p 66
###begin p 67
###xml 69 73 69 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Ying1">[15]</xref>
###xml 90 91 90 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 168 172 <span type="species:ncbi:9913">calf</span>
###xml 309 313 <span type="species:ncbi:9913">calf</span>
Growth in soft agar was assessed essentially as previously described [15]. Briefly, 2.5x104 transfected HCT116 cells were suspended in DMEM medium containing 10% fetal calf serum, 0.35% agar, and 200 microg/ml zeocin. The suspension was then layered on 6 cm plates containing DMEM medium containing 10% fetal calf serum, 0.7% agar, and 200 microg/ml zeocin. Plating was carried out in triplicate and repeated at least twice. Cells were fed every 4-5 days, and after 10-14 days growth, colonies of greater than approximately 50 microm within 10 microscopic fields were counted under a phase contrast microscope. Colony forming efficiency is presented as percentage of colonies larger than 50 microm within total cells.
###end p 67
###begin title 68
Methylated-DNA immunoprecipitation (MeDIP) and chromatin immunoprecipitation (ChIP)
###end title 68
###begin p 69
###xml 620 624 610 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Weber1">[52]</xref>
###xml 625 629 615 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Squazzo1">[53]</xref>
###xml 985 986 975 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 993 994 983 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 421 425 <span type="species:ncbi:9925">goat</span>
###xml 431 436 <span type="species:ncbi:10090">mouse</span>
High molecular weight genomic DNAs were extracted from tissues using standard phenol-chloroform techniques and fragmented to a size range of 200-500 base pairs using a Diagenode Bioruptor. Four micrograms of sonicated genomic DNA and 20 microg anti-5-methyl cytidine monoclonal antibody (Eurogentec, Liege, Belgium) were incubated at 4degreesC overnight in immunoprecipitation buffer, and then for a further 2 hours with goat anti-mouse IgG magnetic beads (N.E. Biolabs). After purification, MeDIP DNA was blunt-ended with T4 DNA polymerase (N.E. Biolabs) and ligation-mediated PCR (LM-PCR) was carried out as described [52],[53]. DNAs were then sent to Nimblegen for labelling and hybridization to Nimblegen HG18 Refseq promoter arrays. Data was analysed using ChipMonk v1.2.1 tiling array analysis software (Dr Simon Andrews, Babraham Institute, Cambridge UK, ). To identify hypermethylated CGIs, a log2ratio cut-off of 1.5 and a window of 500 bp was used to carry out the replicate t-test (P<0.05) on probes within 200 bp of predicted CpG islands (). Additional statistical analysis was carried out using R (). The array data reported in this paper have been deposited in the Gene Expression Omnibus (GEO) database, () under accession number GSE15027.
###end p 69
###begin p 70
###xml 688 696 668 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000745.s012">Table S4</xref>
WiT49 chromatin marks were assessed using a ChIP Kit (Upstate Biotechnology) with antibodies for histone 3 dimethyl lysine 4 (H3K4me2, Upstate Technology), histone 3 dimethyl lysine 9 (H3K9me2, Abcam), and histone 3 acetyl lysine (H3Ac, Upstate). Quantification using real-time PCR was carried out using the Stratagene MX3005P QPCR System (La Jolla, CA) along with the PlatinumSYBR green qPCR SuperMix-UDG (Invitrogen). Reactions volumes of 20 microl contained 10 microl of Platinum SYBRgreen qPCR SuperMix-UDG (Invitrogen, Paisley, UK), 50 nM ROX reference dye, 0.2 microM forward primer, 0.2 microM reverse primer, and 1.5 microl of ChIP DNA template. Primer sequences are available in Table S4.
###end p 70
###begin title 71
Methylation and expression analysis
###end title 71
###begin p 72
###xml 303 311 299 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000745.s012">Table S4</xref>
Up to 1 microg DNA was sodium bisulfite converted using the EZ DNA Methylation-Gold Kit (Zymo Research, CA). Amplicons for combined bisulfite restriction analysis (COBRA) and bisulfite sequencing were made using the Hot Start Red Taq PCR system (Sigma). Primers and restriction enzymes are available in Table S4. For bisulfite sequencing, PCR products were cloned into the pGEM-T-easy cloning vector (Promega), and fluorescently sequenced using standard M13 primer sequences.
###end p 72
###begin p 73
###xml 154 156 150 152 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
###xml 658 666 628 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000745.s012">Table S4</xref>
For comparative quantitative Real-Time RT-PCR, 1 microg of DNAse-treated (TURBO DNA-free, Ambion Inc, TX) total RNA was reverse-transcribed with oligo(dT)20 at 50degreesC for 1 hr using the ThermoScript RT-PCR System (Invitrogen). Real-time PCR was performed using the Stratagene MX3005P QPCR System (La Jolla, CA) along with the PlatinumSYBR green qPCR SuperMix-UDG (Invitrogen). Reactions volumes of 20 microl contained 10 microl of Platinum SYBRgreen qPCR SuperMix-UDG (Invitrogen, Paisley, UK), 50 nM ROX reference dye, 0.2 microM forward primer, 0.2 microM reverse primer, and 2.5 microl of 1:10 diluted cDNA template. Primer sequences are available in Table S4. Thermal cycling consisted of an initial incubation step of 50degreesC for 2 minutes and a denaturation step of 95degreesC for 10 minutes. This was followed by 40 cycles of 95degreesC/15 seconds, 58degreesC/30 seconds, 72degreesC/30 seconds. Gene expression was quantified by comparative Ct method, normalizing values to the housekeeping gene TBP. All assays were performed in duplicate.
###end p 73
###begin title 74
Immunoblotting and immunohistochemistry
###end title 74
###begin p 75
###xml 91 94 91 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Dallosso1">[2]</xref>
###xml 432 438 417 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHG@</italic>
###xml 438 442 423 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Phillips1">[54]</xref>
###xml 443 447 428 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000745-Frank1">[55]</xref>
###xml 331 337 <span type="species:ncbi:9986">rabbit</span>
###xml 484 489 <span type="species:ncbi:9606">human</span>
###xml 494 499 <span type="species:ncbi:10090">mouse</span>
Protein extraction and immunoblotting were carried out essentially as previously described [2] with primary antibodies to beta-catenin (Cell signalling), alpha-tubulin (Sigma) and the gamma-PCDH constant region (Greg Phillips, Mount Sinai School of Medicine, USA). This pan gamma-PCDH antibody is a characterised affinity-purified rabbit polyclonal against a GST-fusion protein containing the constant cytoplasmic domain encoded by PCDHG@[54],[55]. This region is highly conserved in human and mouse, with one amino acid difference in 124 amino-acids. Briefly, tissues were lysed in 300 microl of sample buffer (60 mM Tris pH 6.8, 10% glycerol, 2% SDS, 5% mercaptoethanol) and 10 microg protein was loaded per well and electrophoresed on a 10% SDS - polyacrylamide gel. After electrophoresis the proteins were transferred to Immobilon-P (Millipore) with a semidry transfer apparatus. The Immobilon-P was then transferred to 5% non-fat dry milk (Tesco) in PBS (milk block) and blocked for a minimum of 1 hour. Primary antibodies were incubated in milk block overnight at 4degreesC, followed by the secondary antibody at room temperature for an hour. Protein bands were visualised with ECL Plus reagents (Amersham Pharmacia Biotech).
###end p 75
###begin p 76
###xml 64 69 <span type="species:ncbi:10090">mouse</span>
###xml 304 310 <span type="species:ncbi:9986">Rabbit</span>
For immunohistochemistry, 5 microm sections of CBA x C57Bl/6 F2 mouse P0 neonatal kidney were fixed for 16 hrs in 4% paraformaldehyde. Antigen retrieval of deparaffinised sections was performed by microwaving in 0.8 M urea, pH 6.4, followed by indirect immunoperoxidase staining using the Elite ABC kit (Rabbit IgG; Vectastain) according to the manufacturer's instructions. Primary antibody dilutions were 1:100 for WT1 (6FH2, Dako), and 1:200 for pan gamma-PCDH. Sections were counterstained with haematoxylin. Negative control sections omitted the primary antibody.
###end p 76
###begin title 77
Supporting Information
###end title 77
###begin p 78
###xml 467 470 467 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TBP</italic>
###xml 519 522 519 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H19</italic>
###xml 606 612 606 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASSF1</italic>
###xml 765 768 765 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H19</italic>
###xml 803 809 803 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASSF1</italic>
Analysis of aberrant methylation in Wilms' tumours using Nimblegen Refseq promoter HG18 tiling arrays. (A) The MeDIP-chip workflow used to analyse genome-wide methylation. Methylated DNA purified from normal and tumour DNAs was amplified using ligation-mediated PCR (LM-PCR), labelled and hybridised with promoter microarrays (B) Real-time RT-PCR of MeDIP-enriched tumour DNAs (upper). Enrichment was validated using primers specific to a non-CGI sequence within the TBP gene (grey bars), the constitutively methylated H19 imprinting control region (black bars), and selective enrichment of the methylated RASSF1 5'-CGI in a methylated and unmethylated tumour (open bars). MeDIP DNA was quantified relative to input DNA. The lower panel shows COBRA confirmation of H19 imprinting control region and the RASSF1 5'-CGI methylation status. Arrowheads show methylated (M) and unmethylated (UM) DNA fragments; presence or absence of restriction enzyme is indicated (+/-). (C) The tumour (T) versus normal fetal kidney (N) signal ratio (y-axis) from 17,777 promoter-associated probes are plotted according to their physical location on chromosome 5 (x-axis) for 5 WTs. Hypermethylation at 5q31 is indicated by the vertical arrow.
###end p 78
###begin p 79
(4.67 MB TIF)
###end p 79
###begin p 80
Click here for additional data file.
###end p 80
###begin p 81
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 327 346 327 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD14, TMCO6, NDUFA2</italic>
###xml 351 356 351 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR55</italic>
###xml 421 425 421 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 556 561 556 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH1</italic>
###xml 602 606 602 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
Methylation analysis of genes neighbouring the chromosome 5q31 PCDH cluster. Arrowheads show methylated (M) and unmethylated (UM) DNA fragments; presence or absence of restriction enzyme is indicated (+/-).M+, in vitro methylated DNA (A) Distal neighbours of the clustered PCDHs in normal and tumour tissues. COBRA analysis of CD14, TMCO6, NDUFA2 and WDR55 5'-CGIs (located -153, -147, -139, and -119 kbp upstream of the PCDH clusters, respectively). FK, 22-week fetal kidney; WTs, five pooled WT DNAs. (B) 5'-CGI methylation analysis of the non-clustered PCDH1 gene (located 366 kbp downstream of the PCDH clusters) was carried out on eleven WTs using COBRA. 22-week foetal kidney, FK; FK2, 16-week foetal kidney.
###end p 81
###begin p 82
(1.85 MB TIF)
###end p 82
###begin p 83
Click here for additional data file.
###end p 83
###begin p 84
###xml 24 30 24 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHB6</italic>
###xml 78 84 78 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHB6</italic>
Methylation analysis of PCDHB6 in WT precursor lesions. (A) COBRA analysis of PCDHB6 in DNA extracted from fetal kidney (FK), WTs, and associated perilobar nephrogenic rests (NR). T, Wilms' tumours. Arrowheads show methylated (M) and unmethylated (UM) DNA fragments; presence or absence of restriction enzyme is indicated (+/-). M+, in vitro methylated DNA. (B) Bisulfite sequencing analysis. Black circles represent methylated CpGs and white circles represent unmethylated CpGs.
###end p 84
###begin p 85
(1.22 MB TIF)
###end p 85
###begin p 86
Click here for additional data file.
###end p 86
###begin p 87
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
###xml 87 103 87 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGA3, PCDHGB4</italic>
###xml 109 114 109 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HDAC3</italic>
PCDH hypermethylation in stromal-predominant Wilms' tumours. COBRA was carried out for PCDHGA3, PCDHGB4, and HDAC3. Arrowheads show methylated (M) and unmethylated (UM) DNA fragments; presence or absence of restriction enzyme is indicated (+/-). M+, in vitro methylated DNA.
###end p 87
###begin p 88
(2.02 MB TIF)
###end p 88
###begin p 89
Click here for additional data file.
###end p 89
###begin p 90
###xml 316 329 316 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC25A2. HPRT</italic>
###xml 376 382 376 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DIAPH1</italic>
###xml 387 392 387 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HDAC3</italic>
###xml 464 470 464 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHB@</italic>
###xml 483 489 483 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHG@</italic>
###xml 517 520 517 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TBP</italic>
###xml 536 543 536 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC25A2</italic>
###xml 548 552 548 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAF7</italic>
###xml 645 651 645 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASSF1</italic>
###xml 656 659 656 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H19</italic>
Pharmacological demethylation of WiT49 cells. Quantitative real-time RT-PCR of 5q31 transcripts, mock-treated (-) or 5-azacytidine treated (+) cells. Grey bars indicate genes associated with hypermethylated CGIs, white bars represent genes with CpG islands with no detectable methylation and black bars are used for SLC25A2. HPRT is an X-chromosome housekeeping control gene. DIAPH1 and HDAC3 are located on chromosome 5q31 outside the LRES. Expression data for 3 PCDHB@ genes and 4 PCDHG@ genes is shown relative to TBP, together with SLC25A2 and TAF7 genes, which are located within the LRES. Induction of the WT hypermethylated control genes RASSF1 and H19 is also shown.
###end p 90
###begin p 91
(2.41 MB TIF)
###end p 91
###begin p 92
Click here for additional data file.
###end p 92
###begin p 93
###xml 20 63 20 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGA2, PCDHGA6, PCDHGA12, PCDHB6, PCDHGC3</italic>
###xml 68 75 68 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDHGA7</italic>
Hypermethylation of PCDHGA2, PCDHGA6, PCDHGA12, PCDHB6, PCDHGC3 and PCDHGA7 in HCT116 cells demonstrated using COBRA analysis. Arrowheads show methylated (M) and unmethylated (UM) DNA fragments; presence or absence of restriction enzyme is indicated (+/-).
###end p 93
###begin p 94
(1.25 MB TIF)
###end p 94
###begin p 95
Click here for additional data file.
###end p 95
###begin p 96
###xml 247 253 244 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTNNB1</italic>
###xml 314 318 311 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PCDH</italic>
Suppression of colony formation is not dependent on non-specific toxicity of transfected genes. Mutant beta-catenin (Y33, tyrosine at amino-acid 33) expression does not suppress colony formation in HEK293 cells. HEK293 cells were transfected with CTNNB1 cDNA cloned in the same expression vector (pcDNA3.1/Zeo) as PCDH constructs. After selection and staining, plates were photographed and colony counts determined for each transfection. Representative plates (above) and mean colony counts (below) are shown. Verification of beta-catenin protein expression after transfection is shown by immunoblotting below the histograms, together with tubulin to control loading.
###end p 96
###begin p 97
(1.35 MB TIF)
###end p 97
###begin p 98
Click here for additional data file.
###end p 98
###begin p 99
###xml 24 30 24 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pcdhg@</italic>
###xml 70 77 70 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000745.s013">Text S1</xref>
###xml 148 154 148 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pcdhg@</italic>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
###xml 675 679 <span type="species:ncbi:10090">mice</span>
Kidneys of heterozygous Pcdhg@ mutant mice show no malformations (see Text S1). Histology of three-month old wild-type (wt, n = 2) and heterozygous Pcdhg@ mutant kidneys (het, n = 3) was examined on cryosections. Staining of adjacent sections with cresyl-violet (left column) and nuclear fast red (middle and right columns) was used to highlight the cytoarchitecture of the specimens. The overall morphology of the heterozygous kidneys appeared normal and showed no malformations. Scale bars  = 500 microm. At higher magnifications, findings were comparable in three-month old wild-type and heterozygous littermates and displayed normal cytoarchitecture in aged heterozygous mice (boxed areas are shown in the right column, scale bars  = 100 microm).
###end p 99
###begin p 100
(1.02 MB TIF)
###end p 100
###begin p 101
Click here for additional data file.
###end p 101
###begin p 102
###xml 150 151 150 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Wilms' tumour hypermethylated genes identified by MeDIP-chip. Summary table of hypermethylated genes identified by MeDIP-chip in five Wilms' tumours (P<0.05). Ensembl gene ID, gene symbol, and co-ordinates by chromosome and gene start (HG18 genome build) are given. The frequency of hypermethylation is given in the final column. Blanks in the Gene name column represent Refseq unannotated genes.
###end p 102
###begin p 103
(0.23 MB XLS)
###end p 103
###begin p 104
Click here for additional data file.
###end p 104
###begin p 105
COBRA methylation summary. Methylation data from normal and tumour samples ascertained by combined bisulphite restriction analysis (COBRA). U, unmethylated; M, predominantly methylated; m, partially methylated. L and R, tumours of the left and right kidneys, respectively.
###end p 105
###begin p 106
(0.04 MB XLS)
###end p 106
###begin p 107
Click here for additional data file.
###end p 107
###begin p 108
###xml 333 336 333 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT1</italic>
###xml 362 365 362 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT1</italic>
Clinical details of nephrogenic rests and Wilms' tumours. Age at diagnosis: m, age in months. Histology: FH, favorable histology; UH, unfavorable histology; TR, triphasic; B, blastemal predominant; E; epithelial predominant; S, stromal predominant; A, anaplastic; T, teratoid; R, regressive. Outcome: A, alive; R, relapsed; D, died. WT1 mutation: Y, yes; N, no. WT1 mutation details: G/L, germline. Blank entry, not done.
###end p 108
###begin p 109
(0.02 MB XLS)
###end p 109
###begin p 110
Click here for additional data file.
###end p 110
###begin p 111
Oligonucleotide primers used in this study.
###end p 111
###begin p 112
(0.04 MB XLS)
###end p 112
###begin p 113
Click here for additional data file.
###end p 113
###begin p 114
Supporting information methods.
###end p 114
###begin p 115
(0.03 MB DOC)
###end p 115
###begin p 116
Click here for additional data file.
###end p 116
###begin p 117
The authors wish to thank Vitaliy Androshchuk for excellent support, Iryna Withington for assistance with histology, Greg Phillips for pan gamma-PCDH antibodies, Herman Yeger for WiT49 cells, Randall Moon for Super8x reporter plasmids, and Zsombor Melegh and Jamie Davies for helpful discussions.
###end p 117
###begin title 118
References
###end title 118
###begin article-title 119
Wilms' tumour: connecting tumorigenesis and organ development in the kidney.
###end article-title 119
###begin article-title 120
Genomic Imprinting at the WT1 gene involves a novel coding transcript (AWT1) that shows deregulation in Wilms' tumours.
###end article-title 120
###begin article-title 121
Identification of differential methylation of the WT1 antisense regulatory region and relaxation of imprinting in Wilms' tumor.
###end article-title 121
###begin article-title 122
Relaxation of Insulin-Like Growth Factor-II Gene Imprinting Implicated in Wilms' Tumour.
###end article-title 122
###begin article-title 123
Frequency and timing of loss of imprinting at 11p13 and 11p15 in Wilms' tumor development.
###end article-title 123
###begin article-title 124
The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers.
###end article-title 124
###begin article-title 125
Frequent RASSF1A tumour suppressor gene promoter methylation in Wilms' tumour and colorectal cancer.
###end article-title 125
###begin article-title 126
Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma.
###end article-title 126
###begin article-title 127
Hypomethylation and aberrant expression of the glioma pathogenesis-related 1 gene in Wilms tumors.
###end article-title 127
###begin article-title 128
Protocadherin family: diversity, structure, and function.
###end article-title 128
###begin article-title 129
Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band.
###end article-title 129
###begin article-title 130
Epigenetic inactivation of a cluster of genes flanking MLH1 in microsatellite-unstable colorectal cancer.
###end article-title 130
###begin article-title 131
Epigenetic inactivation of the HOXA gene cluster in breast cancer.
###end article-title 131
###begin article-title 132
Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay.
###end article-title 132
###begin article-title 133
Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation.
###end article-title 133
###begin article-title 134
###xml 96 104 <span type="species:ncbi:9606">patients</span>
Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.
###end article-title 134
###begin article-title 135
###xml 11 16 <span type="species:ncbi:9606">human</span>
PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer.
###end article-title 135
###begin article-title 136
Derivation and characterization of a Wilms' tumour cell line, WiT 49.
###end article-title 136
###begin article-title 137
beta-catenin/TCF/Lef controls a differentiation-associated transcriptional program in renal epithelial progenitors.
###end article-title 137
###begin article-title 138
Presenilin-dependent processing and nuclear function of gamma-protocadherins.
###end article-title 138
###begin article-title 139
Gamma-Protocadherins, presenilin-mediated release of C-terminal fragment promotes locus expression.
###end article-title 139
###begin article-title 140
###xml 2 7 <span type="species:ncbi:9606">human</span>
A human- and male-specific protocadherin that acts through the Wnt signaling pathway to induce neuroendocrine transdifferentiation of prostate cancer cells.
###end article-title 140
###begin article-title 141
WNT/beta-catenin signaling in nephron progenitors and their epithelial progeny.
###end article-title 141
###begin article-title 142
Caught up in a Wnt storm: Wnt signaling in cancer.
###end article-title 142
###begin article-title 143
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements.
###end article-title 143
###begin article-title 144
###xml 40 45 <span type="species:ncbi:9606">human</span>
Heterogeneity of malignant cells from a human colonic carcinoma.
###end article-title 144
###begin article-title 145
###xml 54 59 <span type="species:ncbi:9606">human</span>
Beta-catenin mutations in cell lines established from human colorectal cancers.
###end article-title 145
###begin article-title 146
Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer.
###end article-title 146
###begin article-title 147
CpG island methylator phenotype involving tumor suppressor genes located on chromosome 3p in non-small cell lung cancer.
###end article-title 147
###begin article-title 148
###xml 59 64 <span type="species:ncbi:9606">human</span>
Agglomerative epigenetic aberrations are a common event in human breast cancer.
###end article-title 148
###begin article-title 149
Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene.
###end article-title 149
###begin article-title 150
Evidence for an instructive mechanism of de novo methylation in cancer cells.
###end article-title 150
###begin article-title 151
Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer.
###end article-title 151
###begin article-title 152
###xml 51 56 <span type="species:ncbi:9606">human</span>
Control of developmental regulators by Polycomb in human embryonic stem cells,
###end article-title 152
###begin article-title 153
Hypomethylation and hypermethylation of DNA in Wilms tumors.
###end article-title 153
###begin article-title 154
Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
###end article-title 154
###begin article-title 155
Sequential WT1 and CTNNB1 mutations and alterations of beta-catenin localisation in intralobar nephrogenic rests and associated Wilms tumours: two case studies.
###end article-title 155
###begin article-title 156
Tumor-associated zinc finger mutations in the CTCF transcription factor selectively alter its DNA-binding specificity.
###end article-title 156
###begin article-title 157
###xml 71 76 <span type="species:ncbi:9606">human</span>
Analysis of the vertebrate insulator protein CTCF-binding sites in the human genome.
###end article-title 157
###begin article-title 158
Atlas of gene expression in the developing kidney at microanatomic resolution.
###end article-title 158
###begin article-title 159
Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development.
###end article-title 159
###begin article-title 160
Gamma protocadherins are required for survival of spinal interneurons.
###end article-title 160
###begin article-title 161
###xml 21 26 <span type="species:ncbi:10090">mouse</span>
The wt1-heterozygous mouse; a model to study the development of glomerular sclerosis.
###end article-title 161
###begin article-title 162
###xml 62 67 <span type="species:ncbi:10090">mouse</span>
Wnt/beta-catenin signaling regulates nephron induction during mouse kidney development.
###end article-title 162
###begin article-title 163
Wilms tumor genetics: mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors.
###end article-title 163
###begin article-title 164
Mutational activation of the beta-catenin proto-oncogene is a common event in the development of Wilms' tumors.
###end article-title 164
###begin article-title 165
Wnt signaling and breast cancer.
###end article-title 165
###begin article-title 166
Alpha- and Gamma-Protocadherins negatively regulate PYK2.
###end article-title 166
###begin article-title 167
Proline-rich tyrosine kinase 2 (Pyk2) mediates vascular endothelial-cadherin-based cell-cell adhesion by regulating beta-catenin tyrosine phosphorylation.
###end article-title 167
###begin article-title 168
Phospho-regulation of Beta-catenin adhesion and signaling functions.
###end article-title 168
###begin article-title 169
###xml 21 26 <span type="species:ncbi:9606">human</span>
###xml 61 84 <span type="species:ncbi:28285">human adenovirus type 5</span>
Characteristics of a human cell line transformed by DNA from human adenovirus type 5.
###end article-title 169
###begin article-title 170
###xml 120 125 <span type="species:ncbi:9606">human</span>
Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells.
###end article-title 170
###begin article-title 171
Suz12 binds to silenced regions of the genome in a cell-type-specific manner.
###end article-title 171
###begin article-title 172
Gamma-protocadherins are targeted to subsets of synapses and intracellular organelles in neurons.
###end article-title 172
###begin article-title 173
###xml 66 71 <span type="species:ncbi:10090">mouse</span>
Differential expression of individual gamma-protocadherins during mouse brain development.
###end article-title 173
###begin p 174
The authors have declared that no competing interests exist.
###end p 174
###begin p 175
###xml 76 84 <span type="species:ncbi:9606">Children</span>
This work was supported by Cancer and Leukaemia in Childhood - Sargent, the Children's Leukaemia Trust, and Kidney Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 175

